# Comparative Biosciences, Inc – FDA Inspection, May 17, 2019

Source: https://www.keypedia.com/records/fda_inspections/comparative-biosciences-inc/999e6681-ca7c-4b4b-adab-84dbbf37faab
Source feed: FDA_Inspections

> FDA inspection 1089886 of Comparative Biosciences, Inc, May 17, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 58. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089886
- Company Name: Comparative Biosciences, Inc
- Inspection Date: 2019-05-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1312160 - 2026-04-10](https://www.keypedia.com/records/fda_inspections/comparative-biosciences-inc/400ff501-7b42-4e60-94ba-8c1ed98557cc)
- [FDA Inspection 1245111 - 2024-07-30](https://www.keypedia.com/records/fda_inspections/comparative-biosciences-inc/415506fd-4dfb-4d3a-8f4e-db58c8e90c80)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/comparative-biosciences-inc/c0722afa-cde7-48f7-a4d3-630d5c827079

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df